Food and Drug Administration officials aren't sure just how the two are linked. That's what they told the House subcommittee on Criminal Justice, Drug Policy and Human Resources, investigating the deaths of four women who died of an infection from Clostridium sordellii, a rare but deadly bacterium, after taking the abortion pill Mifeprex (mifepristone). Rep. Mark Souder (R-Ind.) convened the hearing to see if the drug demonstrated a "low standard for women's health," reported the Associated Press (5/17/06).
Food and Drug Administration officials aren't sure just how the two are linked. That's what they told the House subcommittee on Criminal Justice, Drug Policy and Human Resources, investigating the deaths of four women who died of an infection from Clostridium sordellii, a rare but deadly bacterium, after taking the abortion pill Mifeprex (mifepristone). Rep. Mark Souder (R-Ind.) convened the hearing to see if the drug demonstrated a "low standard for women's health," reported the Associated Press (5/17/06).
"It is not possible at this time to determine whether the current mifepristone/misoprostol regimen for abortion results in increased risk of C sordellii infection," said Dr. Janet Woodcock, the FDA's deputy commissioner for operations.
Theories abound, though. Some believe that the drug may suppress the immune system. Others say the infection may indicate an emerging obstetric threat. Opponents of the abortion pill, though, suspect a link and are pointing to the deaths to push for a ban of the drug.
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More